XERIS PHARMACEUTICALS INC: key financial figures for fiscal year 2020 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2020)
- $20.2M
- Net Income/Loss (FY2020)
- -$91.1M
- Total Assets (FY2020)
- $159.2M
- Total Equity (FY2020)
- $33.8M
- Cash Flows from Operating Activities (FY2020)
- -$80.6M
Source: XERIS PHARMACEUTICALS INC 10-K filing (FY2020). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
